Takeaways from the J.P. Morgan annual Healthcare Conference

by David Nolan

As 2023 swings into gear, Talentmark are already out and about getting the inside-track on the key issues facing the life sciences industry. David Nolan has just returned from J.P. Morgan’s annual Healthcare Conference in San Francisco, the most informative healthcare investment and partnering symposium in the industry.

Here are his takeaways for businesses seeking funding based on what global industry leaders, innovative technology creators and members of the investment community have been saying:

• Investors have money to back great science, but valuations must be realistic. If you need to raise capital, focus on defining exactly what’s required to meet your next inflection point and plan that journey in detail.
• Be purposeful and start with the end goal in mind.
• Be capital efficient about how money is spent across operations and growth.
• Series A rounds will be tougher to syndicate.
• Know your capital needs. Focus and resource your projects properly for success – don’t have two ‘leaky boats’.
• Non-life sciences dedicated investors have not understood how valuations change at different inflection points which is overheating the market.
• The traditional IPO route has changed. More creative funding solutions will be needed. Royalty financing coupled with Equity financing will increase.
• Keep a long-term view despite short-term pressures.
• Make the business case backed up by good science – not just good science.